Blockade of CTLA-4 signals inhibits Th2-mediated murine chronic graft- versus-host disease by an enhanced expansion of regulatory CD8+ T cells

Journal of Immunology

Volumn 164, Issue 2, 2000, Pages 664-669

  Sakurai, Jinkyo ^a,b   Ohata, Junko ^a   Saito, Kiyoshi ^a   Miyajima, Hiroaki ^c   Hirano, Takao ^c   Kohsaka, Takao ^a   Enomoto, Shoji ^b   Okumura, Ko ^c   Azuma, Miyuki ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

EID: 0034650487     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.2.664     Document Type: Article

References (57)

1. Linsley, P. S., J. L. Greene, P. Tan, J. Gradshaw, J. A. Ledbetter, C. Anasetti, and N. K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595.
2. Chuang, E., M.-L. Alegre, C. S. Duckett, P. J. Noel, and M. G. V. Heiden. 1997. Interaction of CTLA-4 with the Clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159:144.
3. Shiratori, T., S. Miyatake, H. Ohno, C. Nakaseko, K. Isono, J. S. Bonifacino, and T. Saito. 1997. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adapter complex AP-2. Immunity 6:583.
4. Zhang, Y., and J. P. Allison. 1997. Interaction of CTLA-4 with AP50, a clathrin-coated pit adapter protein. Proc. Natl. Acad. Sci. USA 94:9273.
5. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
6. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production and generation of cytotoxic T lymphocytes. J. Immunol. 154:97.
7. Walunas, T. L., D. J. Lenshow, C. Y. Bakker, D. J. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
8. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
9. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
10. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032.
11. Leach, D. R., M. F. Krummel, and A. J. P. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734.
12. Luhder, F., P. Høglund, J. P. Allison, C. Benoist, and D. Mathis. 1998. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187:427.
13. Perrin, P. J., J. H. Maldonado, T. A. Davis, C. H. June, and M. K. Racke. 1996. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157:1333.
14. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller, and J. A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783.
15. Chambers, C. A., M. F. Krummel, B. Boittel, A. A. Hurwitz, T. J. Sullifvan, S. Foumier, D. Cassell, M. Brunner, and J. P. Allison. 1996. The role of CTLA-4 in the regulation and initiation of T cell responses. Immunol. Rev. 153:27.
16. Perez, V., L. Van Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
17. Judge, T. A., Z. Wu, X. G. Zheng, A. H. Sharpe, M. H, Sayegh, and L. A. Turka. 1999. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J. Immunol. 162:1947.
18. Zheng, X. X., T. G. Markees, W. W. Hancock, Y. Li, D. L. Greiner, X. C. Li, J. P. Mordes, M. H. Sayegh, A. A. Rossini, and T. B. Strom. 1999. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J. Immunol. 162:4983.
19. McCoy, K., M. Camberis, and G. Le Gros. 1997. Protective immunity to nematode infection is induced by CTLA-4 blockade. J. Exp. Med. 186:183.
20. Gleichmann, E., S. T. Pals, A. G. Rolink, T. Radaszliewicz, and H. Gleichman. 1984. Graft-vs-host reactions: clues to the etiopathology of a spectrum of immunological disease. Immunol. Today 5:324.
21. Rozendaal, L., S. T. Pals, M. Schilham, C. J. M. Melief, and E. Gleichmann. 1989. Allosuppression of B cells in vitro by graft-vs-host reaction-derived T cells is caused by cytotoxic T lymphocytes. Eur. J. Immunol. 1989:1669.
22. Allen, R. D., T. A. Staley, and C. L. Sidman. 1993. Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur. J. Immunol. 23: 333.
23. Via, C. S., and G. M. Shearer. 1988. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today 9:207.
24. Goldman, M., P. Druet, and E. Gleichmann. 1991. Th2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically induced autoimmunity. Immunol. Today 12:223.
25. De Wit, D., M. Van Mechelen, C. Zanin, J. Doutrelepont, T. Velu, C. Gërard, D. Abramowicz, J Scheerlinck, P. De Baetelier, J. Urbain, et al. 1993. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 150:361.
26. Blazer, B. R., P. A. Taylor, P. S. Linsley, and D. A. Vallera. 1994. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. Blood 83:3815.
27. Wallace, P. M., J. S. Johnson, J. F. MacMaster, K. A. Kennedy, P. Gladstone, and P. S. Linsley. 1994. CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers. Transplantation 58:602.
28. Saito, K., M. Azuma, H. Hashimoto, H. Yagita, and K. Okumura. 1996. Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease. Eur. J. Immunol. 26:3098.
29. Via, C. S., V. Rus, P. Nguyen, P. Linsley, and W. C. Gause. 1996. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J. Immunol. 157:4258.
30. Saito, K., J. Sakurai, J. Ohata, T. Kohsaka, H. Hashimoto, K. Okumura, R. Abe, and M. Azuma. 1998. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28. J. Immunol. 160:4225.
31. Nuriya, S., H. Yagita, K. Okumura, and M. Azuma. 1996. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity. Int. Immunol. 8:917.
32. Lanier, L. L., and D. J. Recktenwald. 1991. Multicolor immunofluorescence and flow cytometry. Methods 2:192.
33. Azuma, M., T. Hirano, H. Miyajima, N. Watanabe, H. Yagita, S. Enomoto, S. Furusawa, Z. Ovary, T. Kinashi, T. Honjo, and K. Okumura. 1987. Regulation of murine IgE production in SJA/9 and nude mice: potentiation of IgE production by recombinant interleukin 4. J. Immunol 139:2538.
34. Hirano, T., H. Miyajima, H. Kitagawa, N. Watanabe, M. Azuma, O. Taniguchi, H. Hashimoto, H. Yagita, S. Furusawa, Z. Ovary, and K. Okumura. 1988. Studies on murine IgE with monoclonal antibodies. 1. Characterization of rat monoclonal anti-IgE antibodies and the use of these antibodies for determinations of serum IgE levels and for anaphylactic reactions. Int. Archs. Allergy Appl. Immunol. 85:47.
35. a. Immunogenetics 37:301.
36. b. Immungenetics 40: 296.
37. Walunas, T. L., C. Y. Bakker, and J. A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependenl T cell activation. J. Exp. Med. 183:2541.
38. Gleichmann, E., E. H. Van Elven, and J. P. W. Van der Veen. 1982. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol. 12:152.
39. Garlish, C. G., K. J. Pennline, S. R. Smith, M. I. Siegel, and S. P. Umland. 1993. Cytokine gene expression in mice undergoing chronic graft-versus-host disease. Mol. Immunol. 30:669.
40. Doutrelepont, J.-M., M. Moser, O. Leo, D. Abramowicz, M. L. Vanderhaegen, J. Urbain, and M. Goldman. 1991. Hyper IgE in stimulatory graft-versus-host disease: role of interleukin-4. Clin. Exp. Immunol. 83:133.
41. Umland, S. P., S. Razac, D. K. Nahrebne, and B. W. Seymour. 1992. Effects of in vivo adminoistration of interferon (IFN)-γ, anti-IFN-γ, or anti-interleukin-4 monoclonal antibodies in chronic autoimmmune graft-versus-host disease, Clin. Immunol. Immunopathol. 63:66.
42. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fetal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
43. Yang, Y.-F., J.-P. Zou, J. Mu, R. Wijesuriya, S. Ono, T. Walunas, J. Bluestone, H. Fujiwara, and T. Hamaoka. 1997. Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocytes-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages. Cancer Res. 57:4036.
44. + donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference. J. Immunol. 140:2600.
45. Via, C. S. 1991. Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease. J. Immunol. 146:2603.
46. + T cells. J. Immunol. 155:2396.
47. Via, C. S., S. O. Sharrow, and G. M. Shearer. 1987. Role of cylotoxic T lymphocytes in the prevention of lupus-like disease occurring in murine model of graft-vs-host disease. J. Immunol. 139:1840.
48. Fast, L. D. 1991. In vitro characterization of a murine recipient anti-donor effector cell responsible for the development of chronic graft-versus-host disease. J. Immunol. 147:1731.
49. 1) mice. J. Immunol. 156:997.
50. + T cells in immunoglobulin E regulation. Allergy 50 (Suppl. 25):9.
51. + T cells clones. Int. Arch. Allergy Immunol. 113:279.
52. + T cells. Eur. J. Immunol. 27:2657.
53. + T cells inhibit immunoglobulin E synthesis in low responder SJL/J mice. Immunology 93:230.
54. Alegre, M. L., P. J. Noel, B. J. Eisfelder, E. Chuang, M. R. Clark, S. L. Reiner, and C. B. Thompson. 1996. Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J. Immunol. 157:4762.
55. Bachmann, M. F., P. Waterhouse, D. E. Speiser, K. McKall-Faienza, T. W. Mak, and P. S. Ohashi. 1998. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J. Immunol. 160:95.
56. + T cells. Eur. J. Immunol. 28:3137.
57. + T cells. Immunity 7:885.